Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies. [electronic resource]
- European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Mar 2012
- 399-407 p. digital
Publication Type: Journal Article; Review
1879-0720
10.1016/j.ejps.2011.10.015 doi
Animals Antibodies--pharmacology Antibodies, Monoclonal--pharmacology ErbB Receptors--metabolism Humans Immunoglobulin Heavy Chains--pharmacology Nanoparticles--therapeutic use Neoplasms--drug therapy